The Ca(++)-channel blocker Ro 40-5967 blocks differently T-type and L-type Ca++ channels
- PMID: 7996461
The Ca(++)-channel blocker Ro 40-5967 blocks differently T-type and L-type Ca++ channels
Abstract
The effects of Ro 40-5967, a nondihydropyridine Ca++ channel blocker, on low-voltage activated (T-type) and high-voltage activated (L-type) Ca++ channels were compared. L-type barium currents were measured in Chinese hamster ovary cells stably transfected with the alpha 1 subunit of the class Cb Ca++ channel. T-type barium currents were investigated in human medullary thyroid carcinoma cells. The Ba++ currents of human medullary thyroid carcinoma cells were transient, activated at a threshold potential of -50 mV with the maximum at -14 +/- 3.2 mV and blocked by micromolar Ni++. The T- and L-type current inactivated with time constants of 33.4 +/- 4.1 and 416 +/- 26 msec at maximum barium currents, respectively. Ro 40-5967 inhibited reversibly the T- and L-type currents with IC50 values of 2.7 and 18.6 microM, respectively. The inhibition of the L-type current was voltage-dependent, whereas that of the T-type current was not. Ro 40-5967 blocked T-type current already at a holding potential of -100 mV. The different types of block, i.e., voltage-dependent vs. tonic block, may contribute to the pharmacological profile of Ro 40-5967 in intact animals.
Similar articles
-
Voltage-dependent blockade of diverse types of voltage-gated Ca2+ channels expressed in Xenopus oocytes by the Ca2+ channel antagonist mibefradil (Ro 40-5967).Mol Pharmacol. 1995 Sep;48(3):540-9. Mol Pharmacol. 1995. PMID: 7565636
-
Interaction of Ro 40-5967 and verapamil with the stably expressed alpha 1-subunit of the cardiac L-type calcium channel.J Pharmacol Exp Ther. 1995 Jul;274(1):54-63. J Pharmacol Exp Ther. 1995. PMID: 7616442
-
Effect of mibefradil on voltage-dependent gating and kinetics of T-type Ca(2+) channels in cortisol-secreting cells.J Pharmacol Exp Ther. 2000 Jan;292(1):96-103. J Pharmacol Exp Ther. 2000. PMID: 10604935
-
Cardiovascular T-type calcium channels: physiological and pharmacological significance.J Hypertens Suppl. 1997 Dec;15(5):S9-15. J Hypertens Suppl. 1997. PMID: 9481611 Review.
-
Voltage-dependent calcium channels.Gen Physiol Biophys. 2005 Jun;24 Suppl 1:1-78. Gen Physiol Biophys. 2005. PMID: 16096350 Review.
Cited by
-
Calcium signals that determine vascular resistance.Wiley Interdiscip Rev Syst Biol Med. 2019 Sep;11(5):e1448. doi: 10.1002/wsbm.1448. Epub 2019 Mar 18. Wiley Interdiscip Rev Syst Biol Med. 2019. PMID: 30884210 Free PMC article. Review.
-
Amazing T-type calcium channels: updating functional properties in health and disease.Pflugers Arch. 2014 Apr;466(4):623-6. doi: 10.1007/s00424-014-1481-7. Epub 2014 Feb 25. Pflugers Arch. 2014. PMID: 24563221 Review.
-
T-type Ca2+ channels are required for enhanced sympathetic axon growth by TNFα reverse signalling.Open Biol. 2017 Jan;7(1):160288. doi: 10.1098/rsob.160288. Open Biol. 2017. PMID: 28100666 Free PMC article.
-
Antihypertensive effects of mibefradil: a double-blind comparison with diltiazem CD.Clin Cardiol. 1997 Jun;20(6):562-8. doi: 10.1002/clc.4960200610. Clin Cardiol. 1997. PMID: 9181268 Free PMC article. Clinical Trial.
-
Ca2+-Permeable Channels/Ca2+ Signaling in the Regulation of Ileal Na+/Gln Co-Transport in Mice.Front Pharmacol. 2022 Feb 23;13:816133. doi: 10.3389/fphar.2022.816133. eCollection 2022. Front Pharmacol. 2022. PMID: 35281933 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials